Corinne Maurice‐Dror

1.1k citations
35 papers · 576 indexed · 1 hit paper · h-index 12
Topics
Cancer Immunotherapy and Biomarkers (15 papers)Cancer Genomics and Diagnostics (8 papers)Prostate Cancer Treatment and Research (7 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaScientific Reports

In The Last Decade

Corinne Maurice‐Dror

33 papers receiving 571 citations

Hit Papers

First-in-human phase 1 study of the anti-TIGIT antibody v...2021202620222024202150100150

Peers

Corinne Maurice‐Dror
Comparison fields: 5 of 48
  • Oncology 425
  • Immunology 220
  • Pulmonary and Respiratory Medicine 148
  • Molecular Biology 102
  • Surgery 100
Replace Aiwen Wu with:
Aiwen Wu China
Annegé Vledder Netherlands
Audrey Hennequin France
Tatsuki Nanami Japan
Yugang Wu China
Éléonore De Guillebon France
Man Nie China
Jian You China
Marya Chaney United States
Corinne Maurice‐Dror relative to Aiwen Wu China Aiwen Wu's profile →
Citations per field
00.5×6.3×
Aiwen Wu · 1×
Citations per year

Countries citing papers authored by Corinne Maurice‐Dror

Since Specialization
Citations

This map shows the geographic impact of Corinne Maurice‐Dror's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Corinne Maurice‐Dror with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Corinne Maurice‐Dror more than expected).

Fields of papers citing papers by Corinne Maurice‐Dror

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Corinne Maurice‐Dror. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Corinne Maurice‐Dror. The network helps show where Corinne Maurice‐Dror may publish in the future.

Co-authorship network of co-authors of Corinne Maurice‐Dror

This figure shows the co-authorship network connecting the top 25 collaborators of Corinne Maurice‐Dror. A scholar is included among the top collaborators of Corinne Maurice‐Dror based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Corinne Maurice‐Dror. Corinne Maurice‐Dror is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 1
5 6
6 5
7 6
8
First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer☆breakdown →
196
9 23
10 7
11 4
12 6
13 26
14 3
15 19
16 5
17 3
18 3
19 9
20 15

About Corinne Maurice‐Dror

Corinne Maurice‐Dror is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 576 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (15 papers), Cancer Genomics and Diagnostics (8 papers) and Prostate Cancer Treatment and Research (7 papers). The work is most often cited by research in Oncology (425 citations), Immunology (220 citations) and Pulmonary and Respiratory Medicine (148 citations). Corinne Maurice‐Dror has collaborated with scholars based in Israel, United States and Canada. Frequent co-authors include Hyun Cheol Chung, Todd M. Bauer, Ulka N. Vaishampayan, Antonio Jimeno, Jiaxin Niu, Kathryn F. Mileham, Elliot Chartash, Jane Healy, Drew Rasco and D.H. Lee. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026